HomeBUSINESS
BUSINESS

Fujifilm Kicks Off PI Study on FLT3 Inhibitor in US
(Aug.9.2017)

Fujifilm said on August 8 that it has launched a PI clinical trial for its FLT3 inhibitor FF-10101 in the US for the treatment of released/refractory acute myeloid leukemia (AML). The company is eyeing the drug’s launch for this indication in 2022 ...
(LOG IN FOR FULL STORY)

News Calendar